• Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
    • Environmental Risk Assessment of Medicinal Products
  • Team
    • Team
    • Collaborations
  • Insights
    • Insights
    • Cases
    • Publications
  • Careers
  • Contact
  • Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
    • Environmental Risk Assessment of Medicinal Products
  • Team
    • Team
    • Collaborations
  • Insights
    • Insights
    • Cases
    • Publications
  • Careers
  • Contact
  • You are here:
  • Home
  • Dr. Julie Muller

Dr. Julie Muller

Dr. Julie Muller has more than 10 years of professional experience as toxicologist, regulatory expert and HSE manager which she gained via her employment at Solvay SA, Nanocyl SA and lately Penman Consulting. She brings in a wealth of experience in the toxicological risk assessment of chemical substance including nanomaterials and EU Chemicals Regulations.

Julie has a Ph.D. in Biomedical and Pharmaceutical Sciences with an orientation in Toxicology, Genetic and Immunology from the Faculty of Medecine at the Université Catholique de Louvain (UCL) in Brussels, Belgium. Her thesis explored the experimental study of the respiratory toxicity of multi-wall carbon nanotubes.

CONTACT

Dr. Julie Muller
Senior Consultant Product Safety and Regulatory Affairs

Phone: +32 (0)2 762 9145
Email: contact me

 

SPECIALITIES

Chemicals, Nanotechnology, BPR, Regulatory toxicology

INSIGHTS & PUBLICATIONS

The importance of having a solid PC data package to support human health/environmental risk assessment and read across under REACH

News from ECHA’s Committee for Risk Assessment (RAC) – Adoption of Opinion on Harmonised Classification and Labelling for MWCNTs

Nanomaterials in cosmetics – The next priority of the Commission?

Dr. Francesca Tencalla

Previous thumb

Dr. Ankushreddy Patil

Next thumb
Scroll

 

ToxMinds are specialised in ensuring product safety and compliance.

We are passionate about toxicology and how emerging scientific developments can be utilised to support our customers in bringing safe, regulatory compliant and sustainable products to the marketplace.

 

 

 

 

Belgium
ToxMinds BV
Avenue de Tervueren 188A, bte 12
B-1150 Brussels Belgium

VAT BE 0877.628.383

Tel: +32 (0)2 762 9145
Email: contact us

 

 

 

 

India
ToxMinds India Consulting Pvt. Ltd.
Unit 305, 3rd Floor, Brigade IRV Centre, Whitefield, Bangalore-560066, India

 

Tel: +91 804 204 19 20
Email: contact us

 

 

 

 

 

LinkedIN
Copyright and disclaimer | Data privacy
  • Home
  • Industries
  • Services
  • Team
  • Insights
  • Careers
  • Contact
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok